Scientific Program
July 5th / July 6th / July 7th
program pdf
| July 5th, 2007, Aula Magna, Palazzo del Bo' |
| |
|
| |
Welcome Address and Opening Lecture |
| |
Chairman: R Vettor (Padua) |
| 14.00 |
R Mechoulam (Jerusalem) |
Present and future of endocannabinoids research |
| |
|
|
| |
Endocannabinoids: From structure to function |
| |
Chairmen: M Carruba (Milan), G Enzi (Padua)
Discussants: M Dalle Carbonare (Padua) |
| 14.45 |
T Bisogno (Pozzuoli) |
Endogenous cannabinoids: structure and metabolism |
| 15.25 |
K Mackie (Seattle) |
Cannabinoid receptors |
| 16.05 |
A Leon (Padua) |
New cannabinoid compounds |
| |
|
|
| 16.45 |
Coffee Break |
|
| |
|
|
| |
Endocannabinoids in Endocrinology (I)
|
| |
Chairmen: F Mantero (Padua), A Colao (Naples)
Discussant: F. Fallo (Padua) |
| 17.00 |
V Di Marzo (Pozzuoli) |
Central and peripheral regulation of the endocannabinoid system within the framework of energy metabolism |
| 17.40 |
M Maccarrone (Teramo) |
Endocannabinoids, hormone-cytokine networks and human fertility |
| 18.20 |
M Rossato (Padua) |
Endocannabinoids and male reproductive function |
| |
|
|
| 19.00 |
Closing remarks |
|
| July 6th, 2007, Aula Magna, Palazzo del Bo' |
| |
|
Morning sessions |
| |
Endocannabinoids in Endocrinology (II) |
| |
Chairmen: R Pasquali (Bologna), CM Rotella (Florence)
Discussants: E Arvat (Turin), M Boscaro (Ancona) |
| 8.30 |
E Fride (Ariel) |
The role of endocannabinoids in the first periods of life |
| 9.10 |
D Cota (Cincinnati) |
Endocannabinoids and the HPA |
| 9.50 |
I Bab (Jerusalem) |
Endocannabinoids and the regulation of bone metabolism |
| |
|
|
| 10.30 |
Coffee Break |
|
| |
|
|
| |
Endocannabinoids and Metabolic Regulation |
| |
Chairmen: M Muggeo (Verona), S Del Prato (Pisa) Discussants: A Avogaro (Padua) |
| 10.50 |
R Nogueiras (Cincinnati) |
The cannabinoid system and insulin sensitivity |
| 11.30 |
I Matias (Pozzuoli) |
Endocannabinoids in the control of adipocyte and beta-cell function |
| 12.10 |
P Caraceni (Bologna) |
Endocannabinoids and liver diseases |
| 12.50 |
F Rodriguez de Fonseca (Malaga) |
Effect of CB1 antagonists poorly penetrating the blood-brain barrier |
| |
|
|
| 13.30 |
Lunch |
|
|
|
|
Afternoon sessions |
| |
Endocannabinoids and Obesity (I) |
| |
Chairmen: V Di Marzo (Pozzuoli), F. Rohner-Jeanrenaud (Geneva)
Discussants: E Nisoli (Milan), G De Pergola (Bari) |
| 15.00 |
H Hansen (Copenhagen) |
Endocannabinoids and nutrition |
| 15.40 |
A Izzo (Naples) |
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract: focus on feeding behaviour. |
| 16.20 |
U Pagotto (Bologna) |
How CB1 ko mice may help to understand the role of endocannabinoids in the regulation of metabolism and food intake |
| |
|
|
| 17.00 |
Coffee Break |
|
| |
|
|
| |
Endocannabinoids and Obesity (II) |
| |
Chairmen: A Tiengo (Padua), S Cinti (Ancona)
Discussant: F Santini (Pisa) |
| 17.20 |
C Pagano (Padua) |
Endocannabinoids and the regulation of adipose tissue function in humans |
| 18.00 |
S Engeli (Berlin) |
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity |
| 18.40 |
A Scheen (Liege) |
CB1 blockade and its impact on cardiometabolic risk factors |
| |
| 19.20 |
Closing Remarks |
|
| July 7th, 2007, Aula Magna, Palazzo del Bo' |
| |
Morning sessions |
| |
Endocannabinoids in inflammation and cardiovascular disease (I)) |
| |
Chairmen: S Iliceto (Padua), E Agabiti Rosei (Brescia)
Discussants: A Zambon (Padua), F Di Virgilio (Ferrara |
| 8.30 |
O Ullrich (Magdeburg) |
Endocannabinoids and immune system |
| 9.00 |
T Iuvone (Naples) |
Cannabimimetic control of mast cell mediator release: new perspectives in chronic inflammation |
| 9.30 |
Sabine Steffens (Geneva) |
Endocannabinoids in atherosclerosis |
| 10.00 |
R Sarzani (Ancona) |
Endocannabinoids and the heart |
| |
|
|
| 10.30 |
Coffee Break |
|
| |
|
|
| |
Endocannabinoids in inflammation and cardiovascular disease (II) |
| |
Chairmen: R Vettor (Padua), A Mezzetti (Chieti)
Discussant: L Sechi (Udine) |
| 10.50 |
S Batkai (Bethesda) |
Endocannabinoids and the cardiovascular system |
| 11.25 |
G Grassi (Milan) |
Effect of rimonabant on blood pressure: evidence from clinical trials |
| |
|
|
| 12.00 |
Roundtable and Discussion
The future of ECS in Endocrinology, Metabolism and Cardiovascular Diseases: the Efficacy/Safety Benefits of CB1 Blockade in Patients.
Speakers:
A Sheen (Liege), G Grassi (Milan), R Pasquali (Bologna), U Pagotto (Bologna) |
13.00 Closing remarks: R Pasquali (Bologna), R Vettor (Padua)
